All (n=25) | Nonasthma (n=17) | Asthma (n=8) | |||||||
Before | After | p-value | Before | After | p-value | Before | After | p-value | |
FENO50 ppb | 17 (11–24) | 11 (7–17) | <0.001 | 17 (10–24) | 11 (7–18) | <0.001 | 16 (13–28) | 13 (8–16) | 0.012 |
JawNO nL·s−1 | 0.91 (0.60–1.57) | 0.63 (0.33–0.90) | <0.001 | 0.74 (0.55–1.57) | 0.63 (0.26–0.88) | <0.001 | 0.93 (0.68–1.67) | 0.69 (0.42–0.94) | 0.093 |
CawNO ppb | 52 (36–81) | 43 (31–73) | 0.427 | 51 (24–64) | 36 (31–96) | 0.554 | 64 (45–131) | 51 (33–59) | 0.036 |
DawNO mL·s−1 | 20 (15–25) | 16 (8–19) | 0.032 | 21 (16–25) | 11 (7–18) | 0.004 | 16 (8–24) | 19 (11–22) | 0.401 |
CANO ppb | 1.6 (1.1–1.9) | 1.9 (1.6–2.4) | 0.006 | 1.5 (1.0–1.9) | 2.0 (1.6–2.8) | 0.005 | 1.6 (1.4–2.0) | 1.7 (1.4–2.0) | 0.401 |
Data are presented as median (interquartile range), unless otherwise stated. FENO50: baseline exhaled nitric oxide fraction; V′O2max: maximal oxygen uptake; JawNO: the airway flux of NO; CawNO: content of NO in the airway wall; DawNO: diffusing capacity of NO; CANO: alveolar NO.